LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 80

Search options

  1. Article ; Online: Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma through Regulation of Sphingolipid Rheostat.

    Navone, Stefania Elena / Guarnaccia, Laura / Rizzaro, Massimiliano D / Begani, Laura / Barilla, Emanuela / Alotta, Giovanni / Garzia, Emanuele / Caroli, Manuela / Ampollini, Antonella / Violetti, Aniello / Gervasi, Noreen / Campanella, Rolando / Riboni, Laura / Locatelli, Marco / Marfia, Giovanni

    International journal of molecular sciences

    2023  Volume 25, Issue 1

    Abstract: Glioblastoma (GBM) is the most aggressive brain tumor, still considered incurable. In this study, conducted on primary GBM stem cells (GSCs), specifically selected as the most therapy-resistant, we examined the efficacy of luteolin, a natural flavonoid, ... ...

    Abstract Glioblastoma (GBM) is the most aggressive brain tumor, still considered incurable. In this study, conducted on primary GBM stem cells (GSCs), specifically selected as the most therapy-resistant, we examined the efficacy of luteolin, a natural flavonoid, as an anti-tumoral compound. Luteolin is known to impact the sphingolipid rheostat, a pathway regulated by the proliferative sphingosine-1-phosphate (S1P) and the proapoptotic ceramide (Cer), and implicated in numerous oncopromoter biological processes. Here, we report that luteolin is able to inhibit the expression of SphK1/2, the two kinases implicated in S1P formation, and to increase the expression of both SGPL1, the lyase responsible for S1P degradation, and CERS1, the ceramide synthase 1, thus shifting the balance toward the production of ceramide. In addition, luteolin proved to decrease the expression of protumoral signaling as MAPK, RAS/MEK/ERK and PI3K/AKT/mTOR and cyclins involved in cell cycle progression. In parallel, luteolin succeeded in upregulation of proapoptotic mediators as caspases and Bcl-2 family and cell cycle controllers as p53 and p27. Furthermore, luteolin determined the shutdown of autophagy contributing to cell survival. Overall, our data support the use of luteolin as add-on therapy, having demonstrated a good ability in impairing GSC viability and survival and increasing cell sensitivity to TMZ.
    MeSH term(s) Humans ; Sphingolipids ; Glioblastoma/drug therapy ; Luteolin/pharmacology ; Phosphatidylinositol 3-Kinases ; Ceramides ; Lysophospholipids ; Sphingosine/analogs & derivatives
    Chemical Substances Sphingolipids ; Luteolin (KUX1ZNC9J2) ; Phosphatidylinositol 3-Kinases (EC 2.7.1.-) ; Ceramides ; sphingosine 1-phosphate (26993-30-6) ; Lysophospholipids ; Sphingosine (NGZ37HRE42)
    Language English
    Publishing date 2023-12-21
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms25010130
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article ; Online: Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma through Regulation of Sphingolipid Rheostat

    Stefania Elena Navone / Laura Guarnaccia / Massimiliano D. Rizzaro / Laura Begani / Emanuela Barilla / Giovanni Alotta / Emanuele Garzia / Manuela Caroli / Antonella Ampollini / Aniello Violetti / Noreen Gervasi / Rolando Campanella / Laura Riboni / Marco Locatelli / Giovanni Marfia

    International Journal of Molecular Sciences, Vol 25, Iss 1, p

    2023  Volume 130

    Abstract: Glioblastoma (GBM) is the most aggressive brain tumor, still considered incurable. In this study, conducted on primary GBM stem cells (GSCs), specifically selected as the most therapy-resistant, we examined the efficacy of luteolin, a natural flavonoid, ... ...

    Abstract Glioblastoma (GBM) is the most aggressive brain tumor, still considered incurable. In this study, conducted on primary GBM stem cells (GSCs), specifically selected as the most therapy-resistant, we examined the efficacy of luteolin, a natural flavonoid, as an anti-tumoral compound. Luteolin is known to impact the sphingolipid rheostat, a pathway regulated by the proliferative sphingosine-1-phosphate (S1P) and the proapoptotic ceramide (Cer), and implicated in numerous oncopromoter biological processes. Here, we report that luteolin is able to inhibit the expression of SphK1/2, the two kinases implicated in S1P formation, and to increase the expression of both SGPL1, the lyase responsible for S1P degradation, and CERS1, the ceramide synthase 1, thus shifting the balance toward the production of ceramide. In addition, luteolin proved to decrease the expression of protumoral signaling as MAPK, RAS/MEK/ERK and PI3K/AKT/mTOR and cyclins involved in cell cycle progression. In parallel, luteolin succeeded in upregulation of proapoptotic mediators as caspases and Bcl-2 family and cell cycle controllers as p53 and p27. Furthermore, luteolin determined the shutdown of autophagy contributing to cell survival. Overall, our data support the use of luteolin as add-on therapy, having demonstrated a good ability in impairing GSC viability and survival and increasing cell sensitivity to TMZ.
    Keywords glioblastoma stem cells ; luteolin ; sphingosine-1-phosphate ; ceramide ; sphingolipid rheostat ; temozolomide ; Biology (General) ; QH301-705.5 ; Chemistry ; QD1-999
    Subject code 570
    Language English
    Publishing date 2023-12-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    Full text online

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  3. Article ; Online: Multimodal Approach to Outcome Prediction in Metastatic Castration-Resistant Prostate Cancer by Integrating Functional Imaging and Plasma DNA Analysis.

    Conteduca, Vincenza / Scarpi, Emanuela / Matteucci, Federica / Caroli, Paola / Ravaglia, Giorgia / Fantini, Lorenzo / Gurioli, Giorgia / Schepisi, Giuseppe / Wetterskog, Daniel / Menna, Cecilia / Burgio, Salvatore Luca / Lolli, Cristian / Paganelli, Giovanni / Attard, Gerhardt / De Giorgi, Ugo

    JCO precision oncology

    2022  Volume 3, Page(s) 1–13

    Abstract: Purpose: Biomarkers for treatment personalization in metastatic castration-resistant prostate cancer (mCRPC) could help improve patient outcomes. Multiple tests on blood have reported associations with poorer outcome, including serum lactate ... ...

    Abstract Purpose: Biomarkers for treatment personalization in metastatic castration-resistant prostate cancer (mCRPC) could help improve patient outcomes. Multiple tests on blood have reported associations with poorer outcome, including serum lactate dehydrogenase (LDH), chromogranin A (CGA), neutrophil:lymphocyte ratio (NLR), and, recently, copy number (CN) of androgen receptor (AR) in plasma DNA. Biologic data suggest an association between choline uptake and AR signaling. We aimed to integrate 18
    Materials and methods: We determined plasma
    Results: Plasma
    Conclusion: Our results indicate the potential usefulness of integrating functional imaging with plasma DNA analysis and other noninvasive biomarkers as a tool to improve treatment selection for CRPC. A larger prospective evaluation is warranted.
    Language English
    Publishing date 2022-01-31
    Publishing country United States
    Document type Journal Article
    ISSN 2473-4284
    ISSN (online) 2473-4284
    DOI 10.1200/PO.18.00302
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  4. Article ; Online: Flat-Back vs. Arched-Back Bench Press: Examining the Different Techniques Performed by Power Athletes.

    Bartolomei, Sandro / Caroli, Emanuele / Coloretti, Vittorio / Rosaci, Giuseppe / Cortesi, Matteo / Coratella, Giuseppe

    Journal of strength and conditioning research

    2024  

    Abstract: Abstract: Bartolomei, S, Caroli, E, Coloretti, V, Rosaci, G, Cortesi, M, and Coratella, G. Flat ...

    Abstract Abstract: Bartolomei, S, Caroli, E, Coloretti, V, Rosaci, G, Cortesi, M, and Coratella, G. Flat-back vs. arched-back bench press: Examining the different techniques performed by power athletes. J Strength Cond Res XX(X): 000-000, 2024-The International Powerlifting Federation recently changed the regulations concerning the bench press (BP) technique, not allowing an accentuated dorsal arch anymore. We investigated the difference between the flat-back vs. arched-back BP performed by competitive powerlifters as concerns the following parameters: (a) 1 repetition maximum (1RM) and barbell displacement; (b) mean and peak barbell velocity and power, and (c) the excitation of the prime movers. Fifteen highly resistance trained individuals (BP 1RM/body mass ratio: 1.38 ± 0.18) performed the flat-back and arched-back BP at their 50, 70, and 90% of the respective 1RM and performed each lift with the intent to maximally accelerate the barbell. Barbell displacement and velocity, power, and the excitation of the upper and lower pectoralis and triceps brachii were assessed. The 1RM was greater with the arched-back BP (+4.2 Kg, 95% confidence intervals + 0.0/+8.4, effect size [ES]: 0.22), whereas the barbell displacement was greater with the flat-back BP for all loads (ES from 0.40 to 0.61). Greater mean (+0.052 m·s-1, 0.016/0.088, ES: 0.42) and peak barbell velocity (+0.068 m·s-1, +0.026/0.110, ES: 0.27) were observed in the flat-back BP, whereas power did not differ. The excitation of upper and lower pectoralis was similar, while an overall trend for an increased activation of triceps brachii was noted in the arched-back vs. flat-back BP. Interestingly, no between-load difference in the excitation of upper and lower pectoralis was observed (p > 0.05). Depending on the training purposes, both flat-back and arched-back BP may be used. The present outcomes may assist practitioners and competitive powerlifters to inform training session.
    Language English
    Publishing date 2024-03-29
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1156349-7
    ISSN 1533-4287 ; 1064-8011
    ISSN (online) 1533-4287
    ISSN 1064-8011
    DOI 10.1519/JSC.0000000000004778
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 6263: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  5. Article: 68

    Caroli, Paola / Colangione, Sarah Pia / De Giorgi, Ugo / Ghigi, Giulia / Celli, Monica / Scarpi, Emanuela / Monti, Manuela / Di Iorio, Valentina / Sarnelli, Anna / Paganelli, Giovanni / Matteucci, Federica / Romeo, Antonino

    Biomedicines

    2020  Volume 8, Issue 12

    Abstract: 1) Purpose: To investigate the role ... ...

    Abstract (1) Purpose: To investigate the role of
    Language English
    Publishing date 2020-11-25
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2720867-9
    ISSN 2227-9059
    ISSN 2227-9059
    DOI 10.3390/biomedicines8120536
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  6. Article ; Online: Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome.

    Conteduca, Vincenza / Scarpi, Emanuela / Caroli, Paola / Lolli, Cristian / Gurioli, Giorgia / Brighi, Nicole / Poti, Giulia / Farolfi, Alberto / Altavilla, Amelia / Schepisi, Giuseppe / Matteucci, Federica / Paganelli, Giovanni / De Giorgi, Ugo

    Molecular oncology

    2021  Volume 16, Issue 2, Page(s) 538–548

    Abstract: Plasma tumour DNA (ptDNA) is a potential early noninvasive biomarker of treatment outcome in metastatic castration-resistant prostate cancer (mCRPC). Herein, we investigated whether pretreatment ptDNA levels reflect metabolic tumour burden in mCRPC and ... ...

    Abstract Plasma tumour DNA (ptDNA) is a potential early noninvasive biomarker of treatment outcome in metastatic castration-resistant prostate cancer (mCRPC). Herein, we investigated whether pretreatment ptDNA levels reflect metabolic tumour burden in mCRPC and better predict treatment outcome in combination with functional imaging. Targeted next-generation sequencing was performed to estimate the ptDNA fraction from 102 mCRPC patients receiving abiraterone or enzalutamide. The maximum standardized uptake value (SUVmax), total lesion activity (TLA) and metabolic tumour volume (MTV) were evaluated on
    MeSH term(s) Aged ; Humans ; Liquid Biopsy ; Male ; Neoplasm Metastasis ; Prognosis ; Prostatic Neoplasms, Castration-Resistant/pathology ; Prostatic Neoplasms, Castration-Resistant/therapy ; Treatment Outcome
    Language English
    Publishing date 2021-11-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2415106-3
    ISSN 1878-0261 ; 1574-7891
    ISSN (online) 1878-0261
    ISSN 1574-7891
    DOI 10.1002/1878-0261.13120
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 6637: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  7. Article: Neural stem cells and glioblastoma.

    Rispoli, Rossella / Conti, Carlo / Celli, Paolo / Caroli, Emanuela / Carletti, Sandro

    The neuroradiology journal

    2014  Volume 27, Issue 2, Page(s) 169–174

    Abstract: Glioblastoma multiforme represents one of the most common brain cancers with a rather heterogeneous cellular composition, as indicated by the term "multiforme". Recent reports have described the isolation and identification of cancer neural stem cells ... ...

    Abstract Glioblastoma multiforme represents one of the most common brain cancers with a rather heterogeneous cellular composition, as indicated by the term "multiforme". Recent reports have described the isolation and identification of cancer neural stem cells from human adult glioblastoma multiforme, which possess the capacity to establish, sustain, and expand these tumours, even under the challenging settings posed by serial transplantation experiments. Our study focused on the distribution of neural cancer stem cells inside the tumour. The study is divided into three phases: removal of tumoral specimens in different areas of the tumour (centre, periphery, marginal zone) in an operative room equipped with a 1.5 T scanner; isolation and characterization of neural cancer stem cells from human adult glioblastoma multiforme; identification of neural cancer stem cell distribution inside the tumour.
    MeSH term(s) AC133 Antigen ; Adult ; Antigens, CD/metabolism ; Brain Neoplasms/metabolism ; Brain Neoplasms/pathology ; Glioblastoma/metabolism ; Glioblastoma/pathology ; Glycoproteins/metabolism ; Humans ; Imaging, Three-Dimensional ; Immunohistochemistry ; Magnetic Resonance Imaging ; Neoplastic Stem Cells/metabolism ; Neoplastic Stem Cells/pathology ; Neural Stem Cells/metabolism ; Neural Stem Cells/pathology ; Peptides/metabolism ; Spheroids, Cellular ; Tumor Cells, Cultured
    Chemical Substances AC133 Antigen ; Antigens, CD ; Glycoproteins ; Peptides
    Language English
    Publishing date 2014-04-18
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2257770-1
    ISSN 1971-4009 ; 1120-9976
    ISSN 1971-4009 ; 1120-9976
    DOI 10.15274/NRJ-2014-10028
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 2823: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  8. Article ; Online: Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.

    Caroli, Paola / De Giorgi, Ugo / Scarpi, Emanuela / Fantini, Lorenzo / Moretti, Andrea / Galassi, Riccardo / Celli, Monica / Conteduca, Vincenza / Rossi, Lorena / Bianchi, Emanuela / Paganelli, Giovanni / Matteucci, Federica

    European journal of nuclear medicine and molecular imaging

    2017  Volume 45, Issue 3, Page(s) 348–354

    Abstract: Purpose: The role of 18F-choline positron emission tomography/computed tomography (FCH-PET/CT) in patients with metastatic castration-resistant prostate cancer (mCRPC) has been firmly established in recent years. We analyzed the prognostic value of ... ...

    Abstract Purpose: The role of 18F-choline positron emission tomography/computed tomography (FCH-PET/CT) in patients with metastatic castration-resistant prostate cancer (mCRPC) has been firmly established in recent years. We analyzed the prognostic value of functional parameters such as mean standardized uptake volume (SUVmean), maximum standardized uptake volume (SUVmax), metabolic total volume (MTV; the volume of interest consisting of all spatially connected voxels within a fixed threshold of 40% of the SUVmax), and total lesion activity (TLA: the product of MTV and mean standardized uptake value) estimated with FCH-PET/CT in mCRPC patients in progression after docetaxel and treated with new antiandrogen receptor therapies, abiraterone or enzalutamide.
    Methods: We retrospectively studied 94 mCRPC patients, mean age 74 years (range 42-90), previously treated with docetaxel who were treated with either abiraterone (n = 52) or enzalutamide (n = 42). An FCH-PET/CT was performed at baseline, and patients were evaluated on a monthly basis for serological PSA response and every 3 months for radiological response. We measured MTV, SUVmean, SUVmax and TLA for each lesion and analyzed the sum of MTV (SMTV), SUVmean (SSUVmean), SUVmax (SSUVmax) and TLA (STLA) values for a maximum of 20 lesions. Univariate analysis was used to correlate these data with PFS and OS.
    Results: We observed a median SMTV of 130 cm
    Conclusions: Semiquantitative parameters of FCH-PET/CT play a prognostic role in mCRCP patients treated with abiraterone or enzalutamide.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Androstenes/therapeutic use ; Choline/analogs & derivatives ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Phenylthiohydantoin/analogs & derivatives ; Phenylthiohydantoin/therapeutic use ; Positron Emission Tomography Computed Tomography ; Prognosis ; Prospective Studies ; Prostatic Neoplasms, Castration-Resistant/diagnostic imaging ; Prostatic Neoplasms, Castration-Resistant/drug therapy ; Prostatic Neoplasms, Castration-Resistant/metabolism ; Prostatic Neoplasms, Castration-Resistant/pathology ; Reproducibility of Results ; Retrospective Studies
    Chemical Substances Androstenes ; Phenylthiohydantoin (2010-15-3) ; fluorocholine (6029HGL0QP) ; enzalutamide (93T0T9GKNU) ; abiraterone (G819A456D0) ; Choline (N91BDP6H0X)
    Language English
    Publishing date 2017-11-06
    Publishing country Germany
    Document type Clinical Trial ; Journal Article
    ZDB-ID 8236-3
    ISSN 1619-7089 ; 0340-6997 ; 1619-7070
    ISSN (online) 1619-7089
    ISSN 0340-6997 ; 1619-7070
    DOI 10.1007/s00259-017-3866-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 1227: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  9. Article ; Online: Prognostic Nutritional Index Predicts Toxicity in Head and Neck Cancer Patients Treated with Definitive Radiotherapy in Association with Chemotherapy.

    Fanetti, Giuseppe / Polesel, Jerry / Fratta, Elisabetta / Muraro, Elena / Lupato, Valentina / Alfieri, Salvatore / Gobitti, Carlo / Minatel, Emilio / Matrone, Fabio / Caroli, Angela / Revelant, Alberto / Lionello, Marco / Zammattio Polentin, Viviana / Ferretti, Andrea / Guerrieri, Roberto / Chiovati, Paola / Bertolin, Andy / Giacomarra, Vittorio / Paoli, Antonino De /
    Vaccher, Emanuela / Sartor, Giovanna / Steffan, Agostino / Franchin, Giovanni

    Nutrients

    2021  Volume 13, Issue 4

    Abstract: Background: The Prognostic Nutritional Index (PNI) is a parameter of nutritional and inflammation status related to toxicity in cancer treatment. Since data for head and neck cancer are scanty, this study aims to investigate the association between PNI ... ...

    Abstract Background: The Prognostic Nutritional Index (PNI) is a parameter of nutritional and inflammation status related to toxicity in cancer treatment. Since data for head and neck cancer are scanty, this study aims to investigate the association between PNI and acute and late toxicity for this malignancy.
    Methods: A retrospective cohort of 179 head and neck cancer patients treated with definitive radiotherapy with induction/concurrent chemotherapy was followed-up (median follow-up: 38 months) for toxicity and vital status between 2010 and 2017. PNI was calculated according to Onodera formula and low/high PNI levels were defined according to median value. Odds ratio (OR) for acute toxicity were calculated through logistic regression model; hazard ratios (HR) for late toxicity and survival were calculated through the Cox proportional hazards model.
    Results: median PNI was 50.0 (interquartile range: 45.5-53.5). Low PNI was associated with higher risk of weight loss > 10% during treatment (OR = 4.84, 95% CI: 1.73-13.53 for PNI < 50 versus PNI ≥ 50), which was in turn significantly associated with worse overall survival, and higher risk of late mucositis (HR = 1.84; 95% CI:1.09-3.12). PNI predicts acute weight loss >10% and late mucositis.
    Conclusions: PNI could help clinicians to identify patients undergoing radiotherapy who are at high risk of acute and late toxicity.
    MeSH term(s) Aged ; Chemoradiotherapy/adverse effects ; Chemoradiotherapy/methods ; Disease-Free Survival ; Dose Fractionation, Radiation ; Female ; Follow-Up Studies ; Head and Neck Neoplasms/mortality ; Head and Neck Neoplasms/therapy ; Humans ; Induction Chemotherapy/adverse effects ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Mucositis/epidemiology ; Mucositis/etiology ; Nutrition Assessment ; Predictive Value of Tests ; Prognosis ; Radiodermatitis/epidemiology ; Radiodermatitis/etiology ; Radiotherapy, Intensity-Modulated/adverse effects ; Radiotherapy, Intensity-Modulated/methods ; Retrospective Studies ; Risk Assessment ; Weight Loss/drug effects ; Weight Loss/radiation effects
    Language English
    Publishing date 2021-04-13
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2518386-2
    ISSN 2072-6643 ; 2072-6643
    ISSN (online) 2072-6643
    ISSN 2072-6643
    DOI 10.3390/nu13041277
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  10. Article ; Online: Erratum to: Predictive role of dynamic contrast enhanced T1-weighted MR sequences in pre-surgical evaluation of macroadenomas consistency.

    Romano, Andrea / Coppola, Valeria / Lombardi, Mariangela / Lavorato, Luigi / Di Stefano, Domenica / Caroli, Emanuela / Espagnet, Maria Camilla Rossi / Tavanti, Francesca / Minniti, Giuseppe / Trillò, Giuseppe / Bozzao, Alessandro

    Pituitary

    2017  Volume 20, Issue 2, Page(s) 210

    Language English
    Publishing date 2017-04
    Publishing country United States
    Document type Published Erratum
    ZDB-ID 1385151-2
    ISSN 1573-7403 ; 1386-341X
    ISSN (online) 1573-7403
    ISSN 1386-341X
    DOI 10.1007/s11102-016-0774-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 6139: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

To top